David Reardon

David Reardon, MD is a Professor of Medicine at Harvard Medical School and Clinical Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, holding the Alperin Family Chair in Neuro-Oncology. His expertise spans neuro-oncology with clinical interests in anti-angiogenic therapies, immunotherapy, and targeted treatments for brain/spinal tumors. He leads clinical trials and innovative approaches like convection-enhanced delivery.

Education:

• M.D.: Tufts Medical School
• Residency: Johns Hopkins Hospital (Pediatrics)
• Fellowship: University of Michigan Hospital (Pediatric Hematology/Oncology)

Research Focus: Specializing in primary CNS lymphoma, glioblastoma, and brain metastases. Active in translational research bridging laboratory discoveries to clinical applications, particularly in novel therapeutic strategies for malignant brain tumors.

Awards:

• Alperin Family Chair in Neuro-Oncology

Advising/Grants: Leadership in clinical trial design and multidisciplinary care, though specific grant details are not listed. Oversees research teams at Dana-Farber's Neuro-Oncology and CNS Lymphoma centers.

Labs/Teams: Directs research activities within the Center for Neuro-Oncology and CNS Lymphoma Center, collaborating on cutting-edge therapies for central nervous system malignancies.